Compare
Clene Inc. vs Abvc Biopharma, Inc. vs Vyome Holdings, Inc vs BullFrog AI Holdings, Inc.
| Latest fiscal year | Clene Inc. CLNN | Abvc Biopharma, Inc. ABVC | Vyome Holdings, Inc HIND | BullFrog AI Holdings, Inc. BFRG |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $200.0K | $296.0K | $319.7K | $116.7K |
| Revenue growth (YoY) | -41.5% | -41.9% | +24.4% | n/a |
| Gross margin | 78.5% (computed) | n/a | 68.4% | 18.8% |
| Operating margin | n/m | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$26.17M | -$7.91M | -$10.26M | -$6.50M |
| EPS (Diluted) | n/a | -$0.39 | -$4.86 | -$0.63 |
| Operating cash flow | -$18.55M | -$2.99M | -$3.75M | -$5.52M |
| Free cash flow | -$18.59M | n/a | n/a | n/a |
| Cash & equivalents | $5.19M | $681.5K | $4.98M | $2.18M |
| Total assets | $18.13M | $21.06M | $6.50M | $2.81M |
| Total liabilities | $35.72M | $7.76M | $2.74M | $672.0K |
| Shareholders' equity | -$17.59M | $11.11M | $3.76M | $2.14M |
| Return on year-end equity | n/a | -71.2% | -272.8% | -304.2% |
| Shares outstanding | 10.85M | 25.05M | 5.92M | 11.42M |
Revenue, most recent five fiscal years
| Fiscal year | Clene Inc. | Abvc Biopharma, Inc. | Vyome Holdings, Inc | BullFrog AI Holdings, Inc. |
|---|---|---|---|---|
| Latest | $200.0K Ended 2025-12-31 | $296.0K Ended 2025-12-31 | $319.7K Ended 2025-12-31 | $116.7K Ended 2025-12-31 |
| 1 year earlier | $342.0K Ended 2024-12-31 | $509.6K Ended 2024-12-31 | $256.9K Ended 2024-12-31 | n/a |
| 2 years earlier | $654.0K Ended 2023-12-31 | n/a | $8.68M Ended 2023-12-31 | $65.0K Ended 2023-12-31 |
| 3 years earlier | $473.0K Ended 2022-12-31 | n/a | $11.24M Ended 2022-12-31 | $10.0K Ended 2022-12-31 |
| 4 years earlier | $723.0K Ended 2021-12-31 | n/a | $13.60M Ended 2021-12-31 | n/a |